MedTrace Logo

SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer

NCT00900042 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2014-02-25

No results posted yet for this study

Summary

RATIONALE: DNA analysis of tumor tissue may help doctors predict how well patients will respond to treatment.

PURPOSE: This laboratory study is analyzing the DNA in tumor tissue from patients with metastatic kidney cancer.

Conditions

Interventions

GENETIC

DNA ploidy analysis

GENETIC

DNA stability analysis

GENETIC

chromosomal translocation analysis

GENETIC

cytogenetic analysis

OTHER

flow cytometry

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • SWOG Cancer Research Network

    lead NETWORK

Principal Investigators

  • Robert P. Whitehead, MD · University of Texas

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1993-07-31
Primary Completion
2002-12-31
Completion
2003-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00900042 on ClinicalTrials.gov